Phase II Trial Of Weekly Irinotecan And Docetaxel In Recurrent Or Metastatic Head And Neck Carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel; Irinotecan
- Indications Head and neck cancer
- Focus Therapeutic Use
- 09 Nov 2020 Biomarkers information updated
- 28 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2005 New trial record.